Insulin Products As Trump, HHS Take Aim At Prescription Drug Prices
A diabetic person tests blood sugar levels using a Roche Diabetes Care Inc. Accu-Chek brand glucose meter in an arranged photograph taken in the Brooklyn borough of New York, U.S., on Saturday, April 6, 2019. Makers of top-selling insulin products will continue to bear the brunt of Congress' drug-pricing efforts in 2019 as diabetes remains a source of frustration to policy makers in both parties. Photographer: Alex Flynn/Bloomberg via Getty Images
PURCHASE A LICENSE
How can I use this image?
Contact your local office for all commercial or promotional uses.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Bloomberg / Contributor
April 06, 2019
Not released. More information
INSULIN DRUG PRICING
Max file size:
4000 x 2667 px (13.33 x 8.89 in) - 300 dpi - 4 MB